- Service Name
Unigen™
- Industry
Pharmaceutical, biotechnology, drug discovery, immuno-oncology
- Main Value Proposition
Compugen offers a pioneering approach to drug discovery that combines advanced computational tools with deep scientific insights to create innovative cancer therapies.
- Description
Unigen™ is a unique flexible-loop platform developed by Compugen that integrates deep scientific knowledge with AI/ML innovation to discover novel drug targets and develop first-in-class therapeutics for cancer immunotherapy. It aims to transform the pathway to immuno-oncology therapeutics.
- Key Features
Integration of AI/ML for drug target discovery; Development of first-in-class therapeutics; Focus on immuno-oncology treatment options; Evaluation of novel therapeutic antibodies in clinical trials
- Use Cases
Unigen™ is most valuable in scenarios where traditional cancer therapies have failed, providing new treatment options for patients who are refractory or unresponsive to existing drugs.
- Competitive advantages
Proprietary computational tools for drug discovery; Focus on novel pathways and first-in-class drugs; Strong pipeline of clinical trials for innovative therapies
- Strengths
Compugen's strengths lie in its innovative use of AI/ML in drug discovery, a robust pipeline of clinical trials, and a commitment to addressing unmet needs in cancer treatment.
- Positioning
Compugen positions itself as a leader in the field of immuno-oncology, focusing on the development of novel therapeutics that enhance patient responses to existing cancer treatments.
- Audience
The target users include oncologists, cancer researchers, and pharmaceutical companies looking for innovative cancer therapies, as well as patients seeking new treatment options.
- CTA
Learn more »
- Tags
cancer immunotherapy
drug discovery
AI/ML
clinical trials
- Tagline
From Code to Cure®
- Tone of Voice
Innovative, authoritative, optimistic
- Differentiation
Compugen's Unigen™ platform uniquely leverages AI/ML to identify novel drug targets, setting it apart from traditional drug discovery methods that may not utilize such advanced technology.
- Brand Positioning
Compugen's brand identity is centered around innovation in drug discovery and a commitment to improving patient outcomes through advanced scientific research.
- Founded
1993-02-01